The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus

Diabetes, Obesity and Metabolism

Volumn 15, Issue 11, 2013, Pages 1008-1012

  Blomster, J I ^a,b   Chow, C K ^a   Zoungas, S ^a,c   Woodward, M ^a,d   Patel, A ^a   Poulter, N R ^e   Marre, M ^f   Harrap, S ^g   Chalmers, J ^a   Hillis, G S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TURKU   (Finland)

^c MONASH UNIVERSITY   (Australia)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f BICHAT HOSPITAL   (France)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiovascular disease; Diabetes complications; Exercise

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIENOPYRIDINE DERIVATIVE; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROANGIOPATHY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RESTING HEART RATE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

CARDIOVASCULAR DISEASE; DIABETES COMPLICATIONS; EXERCISE;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MICROCIRCULATION; MIDDLE AGED; MORTALITY; MOTOR ACTIVITY; PROPORTIONAL HAZARDS MODELS; RISK; SEDENTARY LIFESTYLE; SEVERITY OF ILLNESS INDEX; VASCULAR DISEASES;

EID: 84885316492     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12122     Document Type: Article

References (23)

1. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005; 28: 1599-1603.
2. Chan JC, Malik V, Jia W et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140.
3. Pate RR, Pratt M, Blair SN et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402-407.
4. Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, Phillips DI, Cooper C. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care 2005; 28: 2541-2542.
5. Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15: 239-246.
6. Pitsavos C, Kavouras SA, Panagiotakos DB et al. Physical activity status and acute coronary syndromes survival The GREECS (Greek Study of Acute Coronary Syndromes) study. J Am Coll Cardiol 2008; 51: 2034-2039.
7. Hu FB, Stampfer MJ, Solomon C et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 2001; 134: 96-105.
8. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 2000; 132: 605-611.
9. Sluik D, Buijsse B, Muckelbauer R et al. Physical activity and mortality in individuals with diabetes mellitus: a prospective study and meta-analysis. Arch Intern Med 2012: 1-11.
10. Study rationale and design of ADVANCE: action in diabetes and vascular disease-preterax and diamicron MR controlled evaluation. Diabetologia 2001; 44: 1118-1120.
11. Patel A, MacMahon S, Chalmers J et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
12. Patel A, MacMahon S, Chalmers J et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829-840.
13. Church TS, Cheng YJ, Earnest CP et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care 2004; 27: 83-88.
14. Church TS, LaMonte MJ, Barlow CE, Blair SN. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med 2005; 165: 2114-2120.
15. Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF, Narayan KM. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med 2003; 163: 1440-1447.
16. Li G, Zhang P, Wang J et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371: 1783-1789.
17. Church TS, Blair SN, Cocreham S et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 2010; 304: 2253-2262.
18. Knudtson MD, Klein R, Klein BE. Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Br J Ophthalmol 2006; 90: 1461-1463.
19. Cruickshanks KJ, Moss SE, Klein R, Klein BE. Physical activity and proliferative retinopathy in people diagnosed with diabetes before age 30yr. Diabetes Care 1992; 15: 1267-1272.
20. Cruickshanks KJ, Moss SE, Klein R, Klein BE. Physical activity and the risk of progression of retinopathy or the development of proliferative retinopathy. Ophthalmology 1995; 102: 1177-1182.
21. Ward KM, Mahan JD, Sherman WM. Aerobic training and diabetic nephropathy in the obese Zucker rat. Ann Clin Lab Sci 1994; 24: 266-277.
22. Ghosh S, Khazaei M, Moien-Afshari F et al. Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice. Am J Physiol Renal Physiol 2009; 296: F700-708.
23. Tufescu A, Kanazawa M, Ishida A et al. Combination of exercise and losartan enhances renoprotective and peripheral effects in spontaneously type 2 diabetes mellitus rats with nephropathy. J Hypertens 2008; 26: 312-321.